Form 8-K - Current report:
SEC Accession No. 0001595585-23-000052
Filing Date
2023-06-13
Accepted
2023-06-13 06:47:55
Documents
17
Period of Report
2023-06-12
Items
Item 1.03: Bankruptcy or Receivership
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcda-20230612.htm   iXBRL 8-K 41046
2 EX-99.1 ex991noticeofeffectiveda.htm EX-99.1 7251
6 ex991noticeofeffectiveda001.jpg GRAPHIC 238768
7 ex991noticeofeffectiveda002.jpg GRAPHIC 158990
8 ex991noticeofeffectiveda003.jpg GRAPHIC 120042
9 tcda-20230612_g1.jpg GRAPHIC 34563
  Complete submission text file 0001595585-23-000052.txt   991636

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20230612.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20230612_lab.xml EX-101.LAB 25151
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20230612_pre.xml EX-101.PRE 13058
11 EXTRACTED XBRL INSTANCE DOCUMENT tcda-20230612_htm.xml XML 11308
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

EIN.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38558 | Film No.: 231010203
SIC: 2834 Pharmaceutical Preparations